These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38792371)

  • 1. The Risk of Venous Thromboembolism and Ischemic Stroke Stratified by VTE Risk Following Multiple Myeloma: A Korean Population-Based Cohort Study.
    Han HJ; Kim M; Lee J; Suh HS
    J Clin Med; 2024 May; 13(10):. PubMed ID: 38792371
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of Short-Term Mortality of Venous Thromboembolism with Family History of Venous Thromboembolism and Charlson Comorbidity Index.
    Zöller B; Pirouzifard M; Sundquist J; Sundquist K
    Thromb Haemost; 2019 Jan; 119(1):48-55. PubMed ID: 30597499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the IMPEDE VTE score for prediction of venous thromboembolism in multiple myeloma: a retrospective cohort study.
    Covut F; Ahmed R; Chawla S; Ricaurte F; Samaras CJ; Anwer F; Garcia AVM; Angelini DE; Mazzoni S; Faiman B; Valent J; Khouri J
    Br J Haematol; 2021 Jun; 193(6):1213-1219. PubMed ID: 33997961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the IMPEDE VTE score for prediction of venous thromboembolism in Chinese patients with multiple myeloma: A single-center retrospective cohort study.
    Bao L; Fang LJ; Xiao MY; Lu MQ; Chu B; Shi L; Gao S; Xiang QQ; Wang YT; Liu X; Ding YH; Xin Z; Chen Y; Wang MZ; Hu WK; Guo CY; Chen LY; Sun K
    Thromb Res; 2024 Apr; 236():130-135. PubMed ID: 38430904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin versus aspirin thromboprophylaxis adds independent value to IMPEDE-VTE score for venous thrombosis prediction in multiple myeloma.
    Bravo-Perez C; Fernández-Caballero M; Soler-Espejo E; Garcia-Torralba E; Sorigue M; García-Malo MD; Jerez A; Vicente V; Roldán V; de Arriba F
    J Thromb Thrombolysis; 2021 Oct; 52(3):848-853. PubMed ID: 33649980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism and effect of comorbidity in bladder cancer: A danish nationwide cohort study of 13,809 patients diagnosed between 1995 and 2011.
    Ording AG; Nielsen ME; Smith AB; Horváth-Puhó E; Sørensen HT
    Urol Oncol; 2016 Jul; 34(7):292.e1-8. PubMed ID: 26971189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint effect of ischemic stroke and obesity on the risk of venous thromboembolism: the Tromsø Study.
    Tøndel BG; Sejrup JK; Morelli VM; Løchen ML; Njølstad I; Mathiesen EB; Wilsgaard T; Hansen JB; Brækkan SK
    Res Pract Thromb Haemost; 2024 Mar; 8(3):102392. PubMed ID: 38665865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of venous thromboembolism after surgery for esophagogastric malignancy and the impact of chemotherapy: a population-based cohort study.
    Adiamah A; Ban L; West J; Humes DJ
    Dis Esophagus; 2020 Jun; 33(6):. PubMed ID: 31617892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous Thromboembolism Risk in Asian Patients with Inflammatory Bowel Disease: A Population-Based Nationwide Inception Cohort Study.
    Kim SY; Cho YS; Kim HS; Lee JK; Kim HM; Park HJ; Kim H; Kim J; Kang DR
    Gut Liver; 2022 Jul; 16(4):555-566. PubMed ID: 34789583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prothrombotic genotypes on the risk of venous thromboembolism in patients with and without ischemic stroke. The Tromsø Study.
    Rinde LB; Morelli VM; Småbrekke B; Mathiesen EB; Løchen ML; Njølstad I; Wilsgaard T; Smith E; Rosendaal FR; Frazer KA; Braekkan SK; Hansen JB
    J Thromb Haemost; 2019 May; 17(5):749-758. PubMed ID: 30773804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease.
    Naik RP; Streiff MB; Haywood C; Segal JB; Lanzkron S
    J Thromb Haemost; 2014 Dec; 12(12):2010-6. PubMed ID: 25280124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer.
    Khorana AA; Palaia J; Rosenblatt L; Pisupati R; Huang N; Nguyen C; Barron J; Gallagher K; Bond TC
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36657815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer, other comorbidity, and risk of venous thromboembolism after stroke: a population-based cohort study.
    Corraini P; Ording AG; Henderson VW; Szépligeti S; Horváth-Puhó E; Sørensen HT
    Thromb Res; 2016 Nov; 147():88-93. PubMed ID: 27710857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive role of CHA2DS2-VASc score between venous thromboembolism and ischemic stroke: a large-scale cohort study.
    Hu WS; Lin CL
    J Hypertens; 2018 Mar; 36(3):628-633. PubMed ID: 28858980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
    Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
    PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study.
    Rinde LB; Småbrekke B; Mathiesen EB; Løchen ML; Njølstad I; Hald EM; Wilsgaard T; Brækkan SK; Hansen JB
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27821402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism and subsequent permanent work-related disability.
    Braekkan SK; Grosse SD; Okoroh EM; Tsai J; Cannegieter SC; Naess IA; Krokstad S; Hansen JB; Skjeldestad FE
    J Thromb Haemost; 2016 Oct; 14(10):1978-1987. PubMed ID: 27411161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score.
    Sanfilippo KM; Luo S; Wang TF; Fiala M; Schoen M; Wildes TM; Mikhael J; Kuderer NM; Calverley DC; Keller J; Thomas T; Carson KR; Gage BF
    Am J Hematol; 2019 Nov; 94(11):1176-1184. PubMed ID: 31379000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk and complications of venous thromboembolism in dialysis patients.
    Molnar AO; Bota SE; McArthur E; Lam NN; Garg AX; Wald R; Zimmerman D; Sood MM
    Nephrol Dial Transplant; 2018 May; 33(5):874-880. PubMed ID: 28992258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of cancer after anticoagulation in patients with unprovoked venous thromboembolism: an observational cohort study.
    Eischer L; Kammer M; Traby L; Kyrle PA; Eichinger S
    J Thromb Haemost; 2017 Jul; 15(7):1368-1374. PubMed ID: 28407356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.